A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00862576

Enrollment

Registered

2009-03-17

Start date

2006-06-30

Completion date

2008-06-30

Last updated

2009-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burning Mouth Syndrome

Keywords

Burning Mouth Syndrome, Sleep, Neuropathic pain, Glossodynia, Chronic pain, Orofacial pain

Brief summary

This is a case control study of the association between burning mouth syndrome and sleep dysfunction. Cases will comprise of patients diagnosed with burning mouth syndrome at the UCSF oral medicine clinic. Controls will include patients with leukoplakia, pigmented lesions, traumatic lesions, benign tumors, mucoceles, and pemphigoid matched on age (5 years) and gender to the cases. New patients as well as those presenting for follow-up visits will be eligible. Each case and control subject will be administered the following 4 questionnaires by interview: (1) enrollment questionnaire (2) Sleep scale from the medical outcomes study (MOS), (3) current sleep status scale and (4) a numerical rating scale for measurement of oral symptoms. Cases (BMS patients) will be followed in the clinic or by telephone contact once per month for the following 6 months and questionnaires 1 (question 6 only), 2, 3 and 4 will be administered by interview.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Cases will comprise of patients diagnosed with burning mouth syndrome at the UCSF oral medicine clinic. * Controls will include patients with leukoplakia, pigmented lesions, traumatic lesions, aphthous ulcers, reticular oral lichen planus, benign tumors, mucoceles, and pemphigoid matched on age (5 years) and gender to the cases. * New patients as well as those presenting for follow-up visits will be eligible.

Exclusion criteria

* Age below 18 years * Pregnancy * Systemic corticosteroid therapy within the previous 2 weeks.

Design outcomes

Primary

Measure	Time frame
Sleep quality and quantity	—

Countries

United States

Outcome results